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First isolated from an ill person in 1985, multidrug-resistant Salmonella enterica serotype Typhimurium
DT104 emerged in the mid-1990s as a strain of Salmonella frequently isolated from humans in the United
States. We compared the integron content, plasmid profile, and XbaI pulsed-field gel electrophoresis
(PFGE) patterns of multidrug-resistant S. Typhimurium DT104 (MR-DT104) isolated from humans in the
United States in 1985, 1990, and 1995. All isolates contained a 60-mDa plasmid and had indistinguishable
PFGE and integron profiles, supporting the idea of a clonal relationship between recent and historical iso-
lates. The data suggest that the widespread emergence of MR-DT104 in humans and animals in the
1990s may have been due to the dissemination of a strain already present in the United States rather than
the introduction of a new strain.
ach year, bacteria of the genus Salmonella infect an esti-
mated 1.4 million persons; these infections result in sev-
eral hundred deaths in the United States annually (1). One of
the most common strains isolated from humans is multidrug-
resistant Salmonella enterica serotype Typhimurium definitive
type 104 (DT104). This strain was first isolated from humans
in 1984 in the United Kingdom, where it emerged as a major
cause of human illness in the late 1980s (2) before its emer-
gence in the United States and elsewhere in the mid-1990s
(3,4). A national sample, in which all state and territorial pub-
lic health laboratories were asked to forward every 10th Sal-
monella isolate to the Centers for Disease Control and
Prevention (CDC) for antimicrobial susceptibility testing,
showed that 275 (28%) of 975 S. Typhimurium isolates from
humans in the United States in 1995 were resistant to ampicil-
lin, chloramphenicol, streptomycin, sulfonamides, and tetracy-
cline (R-type ACSSuT), the resistance pattern commonly
associated with multidrug-resistant DT104 isolates (MR-
DT104). In contrast, only 8 (7%) of 108 S. Typhimurium iso-
lates from humans in sentinel counties in 1990 and 7 (5%) of
135 in 1985 were R-type ACSSuT. An isolate collected in
1985 probably represents the earliest isolate of MR-DT104 in
the United States. After emerging in the mid-1990s, MR-
DT104 has remained prevalent in the United States; in 1999,
114 (31%) of 362 human S. Typhimurium isolates received by
the National Antimicrobial Resistance Monitoring System
(NARMS) for Enteric Bacteria were R-type ACSSuT
(NARMS 1999 Annual Report; http://www.cdc.gov/ncidod/
dbmd/narms). Since Typhimurium was the most common
serotype of Salmonella in the United States in 1999, causing
25% of the culture-confirmed infections (CDC Salmonella
Surveillance, 1999 Annual Summary; http://www.cdc.gov/nci-
dod/dbmd/phlisdata/salmtab/), MR-DT104 caused an esti-
mated 7% of Salmonella infections. 
Food-producing animals are reservoirs for nontyphoidal
Salmonella, and most human Salmonella infections in the
United States are a consequence of eating food, particularly
foods of animal origin, contaminated with Salmonella (5). In
1998, 163 (29%) of 557 S. Typhimurium isolates from animals
received in NARMS were R-type ACSSuT; most of these iso-
lates were collected from cattle and pigs (NARMS 1998 Veter-
inary Isolates Report; http://www.fda.gov/cvm/fda/mappgs/
narms/1998_data/narms_toc.htm ). Limited data are available,
however, on the prevalence of MR-DT104 in food-producing
animals before 1996. A recent report indicates that MR-DT104
became prevalent in cattle in the Pacific Northwest in the mid-
1990s (6); 55 (45%) of 123 cattle S. Typhimurium isolates
from 1995 to 1997 were R-type ACSSuT, compared with 18
(20%) 90 in 1991 to 1994 and 2 (1%) of 163 from 1985 to
1990. Isolates of MR-DT104 from animals and humans were
indistinguishable by molecular subtyping techniques (7).
The genetic determinants responsible for the R-type ACS-
SuT in MR-DT104 are located in the chromosome (2,8).
Molecular characterization of S. Typhimurium DT104 R-type
ACSSuT isolates from Europe and the United States showed
that resistance to ampicillin, streptomycin, and sulfonamides is
associated with the presence of two class-1 integrons (7-10).
First described by Stokes and Hall in 1989 (11), integrons are a
group of apparently mobile elements that can contain one or
more antimicrobial resistance genes. Integrons represent an
important and efficient mechanism by which many bacteria,
including S. Typhimurium DT104, can acquire resistance to
antimicrobial agents. These genetic elements have been found
in a wide variety of organisms and are thought to be largely
responsible for the dramatic increase in multidrug-resistant
bacteria (11-15). Integrons carrying antimicrobial resistance
genes have been found in plasmids and transposons (and trans- Centers for Disease Control and Prevention, Atlanta, Georgia, USA 
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poson-like elements) and in the chromosomal DNA of some
bacteria. The fact that integrons are widely spread among
gram-negative bacteria suggests that these genetic elements
have evolved into a highly adaptable and very efficient mecha-
nism by which cells can acquire and express antimicrobial
resistance genes.
The goal of this study was to compare the integron struc-
ture and gene-cassette content, plasmid profiles, and pulsed-
field electrophoresis (PFGE) patterns of recent S. Typhimu-
rium DT104 (R-type ACSSuT) isolates (1995) with the earli-
est identified isolate of MR-DT104, collected in 1985, as well
as isolates from 1990. The resulting data would suggest
whether the emergence of MR-DT104 in the mid-1990s in
humans and animals resulted from the dissemination of a
strain already present in the United States or from the intro-
duction of a new strain.
Seven S. Typhimurium MR-DT104 strains isolated from ill
persons in 1985 (one isolate), 1990 (three isolates), and 1995
(three isolates) were characterized by polymerase chain reac-
tion (PCR), PFGE, and plasmid profile analysis. MR-DT104
isolates used in this study (Table) were sent to CDC by local
and state health departments and public health laboratories in
1985, 1990, and 1995 as part of national surveys designed to
assess the emergence of antimicrobial resistance in Salmonella
isolates from humans in United States (16,17). These isolates
were serotyped by using a modified version of the method
described by Ewing (18). Sensitivity testing of chosen isolates
(MICs) was conducted by using a panel of 17 antimicrobial
agents (amikacin, amoxicillin-clavulanic acid, ampicillin,
apramycin, ceftiofur, ceftriaxone, cephalothin, chlorampheni-
col, ciprofloxacin, gentamicin, kanamycin, nalidixic acid,
streptomycin, sulfamethoxazole, tetracyline, ticarcillin, and
trimethoprim-sulfamethoxazole) on the Sensititre system
(TREK Diagnostic Systems, Westlake, OH). Phage typing was
done by using the methods of the Laboratory of Enteric Patho-
gens, Central Public Health Laboratory, Public Health Labora-
tory Service, United Kingdom (19). 
PFGE analysis was carried out as described by Barrett et
al. (20), with the following modifications. The DNA in agar-
ose plugs was restricted with 40 U/plug-slice of XbaI restric-
tion enzyme (Roche, Indianapolis, IN), following the
manufacturer’s recommendations. Restriction fragments were
separated by PFGE through 1% SeaKem Gold agarose gels
(BioWhittaker, Rockland, ME) in 0.5X Tris-borate-EDTA (45
mM Tris borate, 1 mM EDTA, pH 8.3 [TBE]) buffer at 14°C
in a CHEF Mapper (Bio-Rad Laboratories, Hercules, CA).
Electrophoresis conditions were as follows: initial switch time
of 2.16 seconds, final switch time of 63.8 seconds, 6 V/cm, at
an angle of 120° for 19 hours. The PFGE profiles (XbaI) of
these isolates were indistinguishable from each other, with the
exception of isolate C5234, which showed an extra band (indi-
cated with an arrow in the Figure) compared with the other
isolates. This level of clonality is remarkable considering that
some of the isolates were obtained 10 years apart. The pre-
dominant PFGE pattern (Figure) was also seen in 21 of 22
additional MR-DT104 R-type ACSSuT isolates from humans
in 1996 tested in our laboratory (E. Ribot, unpub. data). The
remaining isolate had a PFGE pattern indistinguishable from
the pattern of isolate C5234.
Plasmid DNA was isolated by using the QIAfilter plasmid
midi kit (Qiagen, Chatsworth, CA), following the manufac-
turer’s instructions. Plasmid profile analysis was done by load-
ing 15- to 20-µL aliquots into the wells of 1% SeaKem Gold
agarose gels and performing PFGE. The pulsing conditions
were as follows: electrophoresis for 16 hours on a CHEF Map-
per or GenePath System (Bio-Rad), with an initial switch time
6.75 seconds and final switch time 21.7 seconds at 6V/cm. The
running buffer consisted of 0.5X TBE. The buffer temperature
was kept at 14°C during the PFGE run. The plasmid patterns
were visualized by ethidium bromide staining. Plasmid profile
analysis showed that all S. Typhimurium MR-DT104 isolates
contained the 60-mDa plasmid commonly seen in this strain
(data not shown). Additional, smaller plasmids were observed
in some of the isolates (Table). The nature or function of these
smaller plasmids is not known.
Multidrug resistance is associated with the presence of two
integrons found in the chromosomal DNA of S. Typhimurium
MR-DT104 R-type ACSSuT isolates (2,8,9). To investigate
the possibility that these integrons were also present in the S.
Typhimurium DT104 R-type ACSSuT isolates from 1985 and
1990, the first MR-DT104 isolates found in our collection, we
used PCR to amplify gene-cassettes located between the two
Table. Molecular characterization of multidrug-resistant Salmonella Typhimurium DT104 isolates, 1985–1995
Isolate number Year R-type PFGE pattern Plasmid content Amplicons  Gene cassette(s) flo-like genea
B1579 1985 ACSSuT 1 60 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
C3591 1990 ACSSuT 1 60 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
C4501 1990 ACSSuT 1 60 mDa;~5 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
C5234 1990 ACSSuT 1b 60 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
G10217 1995 ACSSuT 1 60 mDa; 3 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
G10518 1995 ACSSuT 1 60 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
G10551 1995 ACSSuT 1 60 mDa 1 kb; 1.2 kb ant(3")-Ia; psE1 +
aAll integrons are located on the chromosome.  
A = ampicillin; C = chloramphenicol; S = streptomycin; Su = sulfamethoxazole; T = tetracycline; PFGE = pulsed-field gel electrophoresis.Emerging Infectious Diseases  •  Vol. 8, No. 4, April 2002 389
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conserved regions (5´-CS and 3´-CS) of class-1 integrons. To
accomplish this, genomic DNA was isolated by using the
Puregene DNA isolation kit (Gentra Systems, Minneapolis,
MN), following the manufacturer’s recommendations. PCR
amplification was performed on both chromosomal DNA and
purified plasmid preparations with synthetic oligonucleotides
5´-CS (5´-GGCATCCAAGCAGCAAG-3´) and 3´-CS (5´-
AAGCAGACTTGACCTGA-3´) (12). PCR was also used to
amplify the region located between the 5´CS and the sulI
(SulI: 5´-TGAAGGTTCGACAGCAC-3´) (12). The cycling
conditions consisted of an initial step at 94°C for 10 minutes,
followed by 35 cycles at 94°C for 20 seconds, 56°C for 20 sec-
onds, and 72°C for 45 seconds with a final extension step of 10
minutes at 72°C. PCR reactions were performed by using Taq
Gold polymerase (PE Biosystems, Foster City, CA) or Taq
DNA polymerase (Roche), under the reactions conditions rec-
ommended by the manufacturers. A PCR System 2400 (PE
Biosystems) was used for all PCR amplifications. The result-
ing PCR amplicons were loaded onto a 1% SeaKem Gold aga-
rose gel and subjected to electrophoresis at 80 volts for 1 hour
and visualized by ethidium bromide staining. 
The PCR amplification with the 5´-CS:3´-CS primer set
yielded two products, a 1-kb and a 1.2-kb fragment (data not
shown). These two fragments represent the gene cassettes con-
tained within two different integrons. The PCR products were
purified by using the QIAquick PCR purification kit (Qiagen).
No amplicons were obtained from any of the plamid prepara-
tions, confirming the chromosomal nature of the antimicrobial
resistance. The purified products were sequenced by the dye
terminator reaction method described in ABI Prism 377 DNA
sequencer (PE Biosystems) instruction manual. DNA
sequence analysis was carried out by using the FASTA algo-
rithm of the GCG Wisconsin package.
Computer analysis showed that the 1-kb fragment con-
tained a gene homologous to the ant(3′′)-1a gene, a gene that
confers resistance to streptomycin and spectinomycin. The
1.2-kb PCR amplicon contained the psE1 gene, which encodes
a beta-lactamase that confers resistance to ampicillin. PCR
ampification with oligonucleotides specific for the 5´-CS and
sulI gene yielded a product of the expected size (approxi-
mately 1.1 kb larger than the product obtained with the 5´-
CS:3´-CS primer set), indicating the presence of sulI, which
confers resistance to sulfonamides.
We were also interested in determining whether resistance
to chloramphenicol was due to the presence of the flo-like
gene described by Bolton et al. in 1999 (21). Detection of flo
was carried out by using the oligonucleotide primers, flo-1 (5´-
AATCACGGGCCACGCTGTATC-3´) and flo-2 (5´-CGC-
CGTCATTCTTCACCTTC-3´) (21). PCR and sequencing data
confirmed that all the isolates carried the florfenicol resistance
(flo-like) gene (data not shown). These findings are consistent
with those of earlier reports (7-9,21) and further demonstrate
the high degree of clonality among isolates of S. Typhimurium
MR-DT104 dating back to 1985.
Our data suggest that the strain of MR-DT104 that became
prevalent during the mid-1990s had not caused frequent
human illness in the United States in 1985 and 1990. Local
health officials interviewed the four patients from whom these
MR-DT104 isolates were collected in 1985 and 1990; none of
them reported traveling outside the United States 30 days
before onset of illness. None reported other underlying ill-
nesses, and none reported taking any antibiotics before speci-
mens were collected. These data suggest that domestic
transmission of MR-DT104 to humans, perhaps through con-
taminated food, occurred in 1985 and 1990. Human infection
with MR-DT104 did not become prevalent, however, until the
mid-1990s. The factors that led to the widespread dissemina-
tion of MR-DT104 in humans in the United States in the mid-
1990s are unknown.
However, the limited animal data available indicate that
MR-DT104 became disseminated in food animals at approxi-
mately the same time (6). Factors that contributed to the dis-
semination of MR-DT104 in animals are poorly understood.
Since food animals are the reservoir for most domestically
acquired human Salmonella infections and transmission from
animals to humans occurs through the food supply (5), the
rapid dissemination of MR-DT104 among humans in the mid-
1990s was likely the consequence of dissemination of MR-
DT104 in food animals during the same period. If this hypoth-
esis is correct, it would parallel the experience of the United
Kingdom, where MR-DT104 was identified as early as 1984
but did not become epidemic in humans until it was estab-
lished in cattle in the late 1980s (2).
Molecular evidence supports the suggestion that some of
the antimicrobial resistance determinants found in S.
Figure. Gel showing the XbaI pulsed-field gel electrophoresis (PFGE)
pattern of each isolate. Lane 1 and 9 show the pattern of the Salmo-
nella strain used as a size standard. Lane 2 shows the pattern of MR-
DT104 strain isolated in 1985. Lanes 3-5 show the patterns of MR-
DT104 isolates obtained in 1990. Lanes 6-8 show the PFGE patterns of
MR-DT104 isolates obtained in 1995.RESEARCH
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Typhimurium DT104 R-type ACSSuT may have emerged,
perhaps in Asia, in the early 1980s in other bacteria and were
transferred horizontally to DT104 (5). For example, chloram-
phenicol resistance in MR-DT104 is encoded by a flo-like
gene that confers resistance to both chloramphenicol and flo-
rfenicol (21,22). flo was first identified in Pasteurella pisci-
cida, the causative agent of pseudotuberculosis, a common
disease of marine fish in Asia (23). Florfenicol was evaluated
as a therapeutic agent in fish in Asia in the early 1980s (22-
26). Kim et al. (27) reported the emergence of florfenicol-
resistant strains of P. piscicida due to the acquisition of trans-
ferable resistance plasmid containing the flo gene, in addition
to other antimicrobial resistance markers (ampicillin, kanamy-
cin, sulfonamide, and tetracycline). Furthermore, nucleotide
sequence analysis of the DNA region containing the florfeni-
col resistance gene and the two tetracycline genetic determi-
nants showed a 94% similarity to a sequence found in a
plasmid from P. piscicida (22). Additional evidence support-
ing the idea of horizontal transfer of multiple antimicrobial
resistance determinants comes from a recent study conducted
on multidrug resistant S. Agona isolates containing a DT104-
like antimicrobial resistance gene cluster in their genome (28). 
In summary, MR-DT104 isolates with indistinguishable
PFGE patterns and carrying the same or highly similar inte-
grons as more recent isolates were present in the United States
as early as 1985. These data and the fact that food-producing
animals are the reservoirs for most human Salmonella infec-
tions in the United States suggest that the emergence of MR-
DT104 during the mid-1990s probably resulted from the dis-
semination of MR-DT104 in food-producing animal reser-
voirs. Laboratory and epidemiologic evidence is insufficient to
determine whether this dissemination resulted from spread of a
strain already present in the United States or the reintroduction
of the strain through importation of contaminated livestock or
other means.
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